Skip to main content
. 2024 Mar 21;45(18):1647–1658. doi: 10.1093/eurheartj/ehae100

Figure 4.

Figure 4

Major adverse kidney events at 12 months. The cumulative incidence (% of population) of major adverse kidney events during the 12-month follow-up period was estimated by the Kaplan–Meier method. Eight additional patients in the placebo arm and three in the Inorganic nitrate arm experienced a major adverse kidney events event between 12 and 13 months. These events happened within the 1-year follow-up window (12 month ± 30 days)